September 2026

Join WhatsApp Channel 

GPAT caoching
Work as Third Party Strategy and Oversight Manager at Bristol Myers Squibb
2 September 2026

Work as Third Party Strategy and Oversight Manager at Bristol Myers Squibb

Bristol Myers Squibb (BMS) is a major global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases, particularly in areas like oncology, immunology, hematology, and cardiovascular conditions, with key products including Opdivo, Eliquis, and Revlimid, aiming to transform patient lives through science. Headquartered in Princeton, New Jersey, BMS has a significant global presence and invests heavily in research and development to address unmet medical needs.

Apply Online for Medical Data Reviewer at ICON plc
2 September 2026
Apply Online for Medical Data Reviewer at ICON plc
Experience in clinical research, pharmacovigilance, or medical monitoring, preferably within a CRO, pharma, or related environment.
Apply Online for Technical Officer at World Health Organization
2 September 2026
Apply Online for Technical Officer at World Health Organization
The objective of the Global Centre for Traditional Medicine (TMC) is to lead WHO's efforts to integrate traditional medicine into global health systems, ensuring safe, effective, and equitable access to traditional medicine practices with focusing on research and evidence, strengthening health systems, sustainability and equity, and innovation and technology.
Dry Eye Remains an Overlooked Menopause Symptom, Bausch and Lomb Survey Reveals
2 September 2026
Dry Eye Remains an Overlooked Menopause Symptom, Bausch and Lomb Survey Reveals
Dry eye is significantly underrecognized as a symptom associated with perimenopause and menopause, according to findings from a new survey conducted by Bausch + Lomb. The survey highlights a substantial awareness gap among women and points to the need for greater attention to eye health during this stage of life.
Novartis’ Remibrutinib Delivers Positive Phase III Results in Relapsing Multiple Sclerosis
2 September 2026
Novartis’ Remibrutinib Delivers Positive Phase III Results in Relapsing Multiple Sclerosis

Novartis has announced positive topline results from the Phase III REMODEL-1 and REMODEL-2 trials evaluating remibrutinib, an oral Bruton’s tyrosine kinase (BTK) inhibitor, in adults with relapsing multiple sclerosis (RMS).

The investigational therapy met the primary endpoint in both trials, demonstrating a statistically significant reduction in annualized relapse rate (ARR) compared with teriflunomide. The studies also reported favorable results across key secondary endpoints, including measures of inflammatory brain lesions seen on MRI.

Central Drugs Laboratory Hiring Pharma candidates
1 September 2026
Central Drugs Laboratory Hiring Pharma candidates
Officers under the Central Government holding analogous posts or with 5 years’ regular service in posts in the scale of Rs. 425-700 or equivalent and possessing the educational qualifications laid down for direct recruits. Central Drugs Laboratory, Kolkata
Northern Institute of Pharmacy & Research looking for Professor, Associate Professor, Assistant Professor
1 September 2026
Northern Institute of Pharmacy & Research looking for Professor, Associate Professor, Assistant Professor
Qualifications, experience, and pay scale shall be as per the norms prescribed by the Pharmacy Council of India (PCI), AICTE, and Rajasthan University of Health Sciences (RUHS), Jaipur. Northern Institute of Pharmacy & Research
Research Recruitment for Pharma candidates under Haryana State Research Fund
1 September 2026
Research Recruitment for Pharma candidates under Haryana State Research Fund
First class M. Pharm. (Pharmaceutical Chemistry); Minimum 60% marks or equivalent CGPA. At least one publication in a SCOPUS/WOS indexed journal. Department of Pharmaceutical Sciences, Gurugram University, Gurugram
Research Fellowships for Pharma, Life Sciences candidates at MAHE
1 September 2026
Research Fellowships for Pharma, Life Sciences candidates at MAHE
Ph.D./ MD/ MS/ MDS or equivalent postgraduate degree. Masters degree in Life Sciences, Health Sciences/ Public Health, Statistics, M. Pharm, M.E., M.Tech or M.Sc. Manipal Academy of Higher Education (MAHE), Manipal
IIT Madras Fellowship - Life Sciences, Biotechnology, Biochemistry, Microbiology Apply
1 September 2026
IIT Madras Fellowship - Life Sciences, Biotechnology, Biochemistry, Microbiology Apply
Masters degree (M.Sc./M.Tech./M.E./M.V.Sc. or equivalent) in a relevant discipline (Biomedical Engineering, Life Sciences, Biotechnology, Biochemistry, Microbiology, etc., ), generally with first class or minimum 80% marks. Department of Biotechnology, IIT Madras